Grant: Discovery Grants Program - Individual
University of Alberta
$80,000.00
Nutritional management of dairy cows to enhance gut functions
EF 2023-24
Résumé
The objective of the proposed research is to evaluate novel nutritional management approaches to enhance gut functions. I have been working to mitigate sub-acute rumen acidosis (SARA) in dairy cows with the support of my NSERC Discovery Grant. The SARA is a metabolic disorder that negatively affects the health and productivity of ruminants. Feeding high grain diets often causes excess fermentation that results in the accumulation of fermentation acids in the rumen (the first stomach of ruminants), leading to systemic inflammation, feed intake reduction, liver abscesses, lameness, and other metabolic disorders. However, it is noteworthy that some animals maintain high feed intake and milk production even with low rumen pH (i.e., SARA). The variable tolerance observed among animals to this condition is not well understood, and the underlying factors warrant investigation. For the current proposal, I hypothesize that glucagon-like peptide 2 (GLP-2), a hormone released from the distal intestine, plays an important role in enhancing gut functions and mitigates the negative consequences of SARA. Because rumen acidosis and excess hind-gut fermentation often increases the entry of lipopolysaccharide, an endotoxin, into blood circulation, enhancing gut barrier function is considered very important to minimize the negative consequences of excess fermentation in the gut. It is well established that GLP-2 plays an important role in gut development and sound gut function, but it is not known how it is involved in minimizing problems related to SARA. I plan to use an acidosis challenge model, where 5 kg of ground grain will be fed after a 2-d 50% feed restriction, to determine if negative effects of SARA would be reduced by continuous administration of a GLP-2 analogue. Furthermore, I will evaluate several nutritional management approaches to potentially enhance plasma GLP-2 concentration, such as butyrate supplementation. I hypothesize that enhancing GLP-2 secretion will minimize systemic inflammation indicated by the serum concentration of acute phase proteins. The proposed research will also investigate the role of supplemental zinc on gut integrity and evaluate if it would minimize systemic inflammation caused by SARA. The proposed research is expected to contribute to sustainable dairy production in Canada by minimizing systemic metabolic problems caused by SARA.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2019-04012
Name nom
Oba, Masahito
Department département
Agricultural, Food and Nutritional Science
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2019
Award amount
80000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Animal physiology and metabolism
Research subject en
Biologie animale
Research subject fr
Physiologie et métabolisme des animaux
Application title
Nutritional management of dairy cows to enhance gut functions
Keyword
Butyrate; Calving transition management; Dairy cows; Glucagon like peptide 2; Gut functions; Inflammatory responses; Rumen acidosis; Zinc
Application summary
The objective of the proposed research is to evaluate novel nutritional management approaches to enhance gut functions. I have been working to mitigate sub-acute rumen acidosis (SARA) in dairy cows with the support of my NSERC Discovery Grant. The SARA is a metabolic disorder that negatively affects the health and productivity of ruminants. Feeding high grain diets often causes excess fermentation that results in the accumulation of fermentation acids in the rumen (the first stomach of ruminants), leading to systemic inflammation, feed intake reduction, liver abscesses, lameness, and other metabolic disorders. However, it is noteworthy that some animals maintain high feed intake and milk production even with low rumen pH (i.e., SARA). The variable tolerance observed among animals to this condition is not well understood, and the underlying factors warrant investigation. For the current proposal, I hypothesize that glucagon-like peptide 2 (GLP-2), a hormone released from the distal intestine, plays an important role in enhancing gut functions and mitigates the negative consequences of SARA. Because rumen acidosis and excess hind-gut fermentation often increases the entry of lipopolysaccharide, an endotoxin, into blood circulation, enhancing gut barrier function is considered very important to minimize the negative consequences of excess fermentation in the gut. It is well established that GLP-2 plays an important role in gut development and sound gut function, but it is not known how it is involved in minimizing problems related to SARA. I plan to use an acidosis challenge model, where 5 kg of ground grain will be fed after a 2-d 50% feed restriction, to determine if negative effects of SARA would be reduced by continuous administration of a GLP-2 analogue. Furthermore, I will evaluate several nutritional management approaches to potentially enhance plasma GLP-2 concentration, such as butyrate supplementation. I hypothesize that enhancing GLP-2 secretion will minimize systemic inflammation indicated by the serum concentration of acute phase proteins. The proposed research will also investigate the role of supplemental zinc on gut integrity and evaluate if it would minimize systemic inflammation caused by SARA. The proposed research is expected to contribute to sustainable dairy production in Canada by minimizing systemic metabolic problems caused by SARA.